About BosterBio
BosterBio is a Healthcare company based in Pleasanton (United States) founded in 1993 by Steven Xia. It specializes in manufacturing antibodies for research and medical applications. It operates on a B2B model. Its website bosterbio.com draws about 82 thousand monthly visits. Its focus areas include Biotechnology, Antibody Production and Manufacturing. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
BosterBio operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, antibody production, and producing manufactured goods. Specializes in manufacturing antibodies for research and medical applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Pleasanton, United States
- Founders Steven Xia
- SectorsHealthcare
- Phone•••• ••••
- Website bosterbio.com
- Social LinkedIn X Facebook
People of BosterBio
2 people are tracked at BosterBio (2 in leadership).
| Name | Role | Group |
|---|---|---|
Steven Xia | Founder, President | Leadership |
CJ Xia | VP of Marketing and Sales | Leadership |
Complete people profiles for BosterBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of BosterBio
BosterBio has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of BosterBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BosterBio
The website of BosterBio (bosterbio.com) receives about 81.8K visits a month.
- Monthly visits81.8K
▼ 9.1% vs previous month
Websites whose visitors overlap most with BosterBio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cygnustechnologies.com | 85% | 8K | #2,705,520 | View details | |
| seracare.com | 83% | 19.3K | #1,387,775 | View details | |
| alpco.com | 77% | 22.6K | #1,367,181 | View details | |
| rockland.com | 77% | 51.8K | #719,362 | View details | |
| biovendor.com | 74% | 21.2K | #1,380,534 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for BosterBio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as BosterBio (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bosterbio
Complete news archive for BosterBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BosterBio
BosterBio was founded in 1993.
BosterBio is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
BosterBio operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, antibody production, and producing manufactured goods. Specializes in manufacturing antibodies for research and medical applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
BosterBio's top competitors include GenScript, Epitomics and Vector Laboratories.